Novartis
Novartis is a Swiss drug company. It makes Leqvio (inclisiran), is a collaborator on the ORION-4 inclisiran outcome trial, and sponsored the Lp(a)HORIZON trial of pelacarsen, which it reported in September 2026 had missed its main goal.
Also called Novartis AG · Novartis Pharmaceuticals
- Organization
- In this atlas
Overview
Technical summary
ROR record 02f9zrr09, Switzerland, listed with the types company and funder. The Leqvio label record gives Novartis Pharmaceuticals Corporation as manufacturer and the US drug-approvals database gives NOVARTIS as applicant on NDA214012. ClinicalTrials.gov lists Novartis Pharmaceuticals as lead sponsor of Lp(a)HORIZON (NCT04023552) and as a collaborator on ORION-4 (NCT03705234). The registry names the entity Novartis Pharmaceuticals and the ROR record names the parent company; this page treats them as one organization for navigation.
Roles
- Company
Sector
Industry
Record details
- Record id
cardio:novartis- Content hash
5fb1984c457a00e924ddc97de0b108647524d5f11f3e068e03b8ac054385a21c